NCT00535574 Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia Status COMPLETED Phase PHASE3
NCT00535145 Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease Status COMPLETED Phase PHASE4
NCT00535132 Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone Status COMPLETED Phase PHASE4
NCT00534898 Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients Status WITHDRAWN Phase PHASE3
NCT00534222 Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect Status COMPLETED Phase N/A
NCT00533260 A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) Status COMPLETED Phase N/A
NCT00531518 Early Detection and Intervention for the Prevention of Psychosis Status COMPLETED Phase NA
NCT00528905 Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00528359 β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS Status COMPLETED Phase N/A
NCT00526877 An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment Status COMPLETED Phase PHASE4
NCT00525304 A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition Status COMPLETED Phase NA
NCT00524043 An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00523445 The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia Status COMPLETED Phase PHASE3